I dont know where you get this burn rate from. We
Post# of 148166
To estimate the actual Cash, its wise to not just look at the last Q10 in Biotechs.
You missed the inflows from the warrants, and the $15 Mio. debt financing, which we had just last week. So its more like $20-$25Mio cash.
To compare mainly the financials and not the pipeline is an very interesting approach to Biotechs as well ...
all imo